Elevated plasma cysteinylglycine levels caused by cilastatin-associated antibiotic treatment

References

1 Ueland PM, Mansoor MA, Gutterson AB, Refsum HM, Aukrust P, Svardal AM. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status – a possible element of the extracellular antioxidant defense system. J Nutr 1996; 126: 1281S–84S. 10.1093/jn/126.suppl_4.1281SSearch in Google Scholar

2 Garibotto G, Sofia A, Safiotti S, Russo R, Deferrari G, Rossi D, et al. Interorgan exchange of aminothiols in humans. Am J Physiol Endocrinol Metab 2003; 284: E757–63. 10.1152/ajpendo.00403.2002Search in Google Scholar

3 Mansoor MA, Bergmark C, Svardal A, Ueland PM. Redox status and protein binding of plasma homocysteine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 1995; 15: 232–40. 10.1161/01.ATV.15.2.232Search in Google Scholar

4 Suliman ME, Barany P, Divino Filho JC, Qureshi AR, Stenvinkel P, Heimburger O, et al. Influence of nutritional status on plasma and erythrocyte sulphur amino acids, sulph-hydryls, and inorganic sulphate in end-stage renal disease. Nephrol Dial Transplant 2002; 17: 1050–6. 10.1093/ndt/17.6.1050Search in Google Scholar

5 Bicikova M, Ripovna D, Hill M, Jirak R, Havlikova H, Tallova J, et al. Plasma levels of 7-hydroxylated dehydroepiandrosterone (DHEA) metabolites and selected amino-thiols as discriminatory tools of Alzheimer's dis-ease and vascular dementia. Clin Chem Lab Med 2004; 42: 518–24. 10.1515/CCLM.2004.088Search in Google Scholar

6 Ozkan Y, Ozkan E, Simsek B. Plasma total homocysteine and cysteine levels as cardiovascular risk factors in coronary heart disease. Int J Cardiol 2002; 82: 269–77. 10.1016/S0167-5273(02)00010-4Search in Google Scholar

7 Crane MS, Ollosson R, Moore KP, Rossi A, Megson IL. Novel role for low molecular weight plasma thiols in nitric oxide-mediated control of platelet function. J Biol Chem 2002; 49: 46858–63. 10.1074/jbc.M208608200Search in Google Scholar PubMed

8 Andersson A, Ankerst J, Lingren A, Larsson K, Hultberg B. Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive pulmonary disease. Clin Chem Lab Med 2001; 39: 229–33. 10.1515/CCLM.2001.036Search in Google Scholar PubMed

9 Barza M. Imipenem: first of a new class of beta-lactam antibiotics. Ann Intern Med 1985; 103: 552–60. 10.7326/0003-4819-103-4-552Search in Google Scholar PubMed

10 Bonfiglio G, Russo G, Nicoletti G. Recent developments in carbapenems. Expert Opin Invest Drugs 2002; 11: 529–44. 10.1517/13543784.11.4.529Search in Google Scholar PubMed

11 Verpooten GA, Verbist L, Buntinx AP, Entwistle LA, Jones KH, De Broe ME. The pharmacokinetics of imipenem (thienamycin-formamide) and the renal dehydropeptidase cilastatin sodium in normal subjects and patients with renal failure. Br J Clin Pharmacol 1984; 18: 183–93. 10.1111/j.1365-2125.1984.tb02451.xSearch in Google Scholar

12 Smyth TP, Wall JG, Nitanai Y. A substrate variant as a high-affinity, reversible inhibitor: insight from the X-ray structure of cilastatin bound to membrane dipeptidase. Bioorg Med Chem 2003; 11: 991–8. 10.1016/S0968-0896(02)00519-9Search in Google Scholar

13 Le Gall JR, Lemeshow S, Saulnier F. A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. J Am Med Assoc 1993; 270: 2957–63. 10.1001/jama.1993.03510240069035Search in Google Scholar

14 Moat SJ, Bonham JR, Powers HJ. Role of aminothiols as a component of the plasma antioxidant system and relevance to homocysteine-mediated vascular disease. Clin Sci (Lond) 2001; 100: 73–9. 10.1042/CS20000152Search in Google Scholar

15 Wu G, Fang YZ, Yang S, Lupton JR, Turner ND. Glutathione metabolism and its implications for health. J Nutr 2004; 134: 489–92. 10.1093/jn/134.3.489Search in Google Scholar

16 Kretzschmar M. Regulation of hepatic glutathione metabolism and its role in hepatotoxicity. Exp Toxicol Pathol 1996; 48: 439–46. 10.1016/S0940-2993(96)80054-6Search in Google Scholar

17 Rahman I, MacNee W. Oxidative stress and regulation of glutathione in lung inflammation. Eur Respir J 2000; 16: 534–54. 10.1034/j.1399-3003.2000.016003534.xSearch in Google Scholar

18 Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000; 267: 4904–11. 10.1046/j.1432-1327.2000.01595.xSearch in Google Scholar

19 Pastore A, Federici G, Bertini E, Piemonte F. Analysis of glutathione: implication in redox and detoxification. Clin Chim Acta 2003; 333: 19–39. 10.1016/S0009-8981(03)00200-6Search in Google Scholar

20 Leo RJ, Ballow CH. Seizure activity associated with imipenem use: clinical case reports and review of the literature. DICP Ann Pharmacother 1991; 25: 351–4. Search in Google Scholar

21 Karadeniz C, Oguz A, Canter B, Serdaroglu A. Incidence of seizures in pediatric cancer patients treated with imipenem/cilastatin. Pediatr Hematol Oncol 2000; 17: 585–90. 10.1080/08880010050122852Search in Google Scholar PubMed